At Yale EMD, we’re advancing the health of everyday Americans—and communities worldwide—through science that tackles today’s most urgent infectious diseases and related threats. 🧵👇
#PublicHealth #GlobalHealth #YaleEMD
#globalhealth @yalesph.bsky.social
#globalhealth @yalesph.bsky.social
📅 Sept 16 | 11:00 ET → Sept 17 | 11:00 ET
For 40+ years, HIV/AIDS research has saved tens of millions of lives. Now, funding cuts threaten to undo that progress.
On Sept 16, scientists, researchers & advocates worldwide will gather for 24 hours....
📅 Sept 16 | 11:00 ET → Sept 17 | 11:00 ET
For 40+ years, HIV/AIDS research has saved tens of millions of lives. Now, funding cuts threaten to undo that progress.
On Sept 16, scientists, researchers & advocates worldwide will gather for 24 hours....
#PublicHealth
Read more: doi.org/10.1371/jour...
#PublicHealth
Read more: doi.org/10.1371/jour...
"Just as disease knows no national boundaries, so also the benefits of medical research and indeed research itself can know no boundaries."
"Just as disease knows no national boundaries, so also the benefits of medical research and indeed research itself can know no boundaries."
@yalesph.bsky.social
@yalesph.bsky.social
It’s a big shift for how NIH-funded research is shared—and especially important for HIV and global health researchers.
YIGH and @CIRAatYale recently hosted a panel to bring the HIV community up to date on what's new in OA publishing. 🧵👇
It’s a big shift for how NIH-funded research is shared—and especially important for HIV and global health researchers.
YIGH and @CIRAatYale recently hosted a panel to bring the HIV community up to date on what's new in OA publishing. 🧵👇
👏👏👏 Congratulations to EMD faculty Robert Heimer & Lauretta Grau for their roles in a major new Yale study on opioid overdose, just published in Drug and Alcohol Dependence.
🔗 medicine.yale.edu/internal-medicine/news-article/opioid-overdose-crisis-medications-prevent-subsequent-overdoses/
👏👏👏 Congratulations to EMD faculty Robert Heimer & Lauretta Grau for their roles in a major new Yale study on opioid overdose, just published in Drug and Alcohol Dependence.
🔗 medicine.yale.edu/internal-medicine/news-article/opioid-overdose-crisis-medications-prevent-subsequent-overdoses/
At Yale EMD, we’re advancing the health of everyday Americans—and communities worldwide—through science that tackles today’s most urgent infectious diseases and related threats. 🧵👇
#PublicHealth #GlobalHealth #YaleEMD
At Yale EMD, we’re advancing the health of everyday Americans—and communities worldwide—through science that tackles today’s most urgent infectious diseases and related threats. 🧵👇
#PublicHealth #GlobalHealth #YaleEMD
Dr. Morgan Goheen is a postdoctoral fellow in the Parikh and Bei Labs, whose research investigates the impact of human antimalarials ingested by mosquitoes feeding on people taking these drugs, parasite development, and selection within the vector.
Dr. Morgan Goheen is a postdoctoral fellow in the Parikh and Bei Labs, whose research investigates the impact of human antimalarials ingested by mosquitoes feeding on people taking these drugs, parasite development, and selection within the vector.
🔗 Read her full article here: lnkd.in/ehxReXUu
🔗 Read her full article here: lnkd.in/ehxReXUu
Afeez Sodeinde, a PhD student in the Vogels and Grubaugh Labs, studies how dengue evolves and how Wolbachia impacts the virus. His work shows that we need tailored vector control strategies, not one-size-fits-all.
👉 Learn more here: medicine.yale.edu/news-article...
Afeez Sodeinde, a PhD student in the Vogels and Grubaugh Labs, studies how dengue evolves and how Wolbachia impacts the virus. His work shows that we need tailored vector control strategies, not one-size-fits-all.
👉 Learn more here: medicine.yale.edu/news-article...
Meet Nicole Feriancek, a PhD student in the Vogels and Grubaugh Labs, sequencing over 3,000 West Nile virus samples in Connecticut. Her work tracks how the virus spreads and evolves across the state.
👉 Learn more here: medicine.yale.edu/news-article...
Meet Nicole Feriancek, a PhD student in the Vogels and Grubaugh Labs, sequencing over 3,000 West Nile virus samples in Connecticut. Her work tracks how the virus spreads and evolves across the state.
👉 Learn more here: medicine.yale.edu/news-article...
@yalesph.bsky.social @cappmic.bsky.social
#publichealth #infectiousdiseases
@yalesph.bsky.social @cappmic.bsky.social
#publichealth #infectiousdiseases
🦠 Today’s spotlight features Karthika Satyanarayanan, an MPH student in the Ko Lab, whose work focuses on Wolbachia-based interventions to decrease the incidence of dengue in Rio de Janeiro.
Fascinating, right? 🌍🦟
👉 Read more here: medicine.yale.edu/news-article...
🦠 Today’s spotlight features Karthika Satyanarayanan, an MPH student in the Ko Lab, whose work focuses on Wolbachia-based interventions to decrease the incidence of dengue in Rio de Janeiro.
Fascinating, right? 🌍🦟
👉 Read more here: medicine.yale.edu/news-article...
📍 The Texas outbreak continues, though it appears to be slowing in some areas.
📍 The numbers in El Paso are increasing at a rapid pace.
📍 Kansas numbers are rising and likely under-reported.
📍 We have a new outbreak in North Dakota.
📍 The Texas outbreak continues, though it appears to be slowing in some areas.
📍 The numbers in El Paso are increasing at a rapid pace.
📍 Kansas numbers are rising and likely under-reported.
📍 We have a new outbreak in North Dakota.
journals.plos.org/plosntds/art...
journals.plos.org/plosntds/art...
What a day! Our brilliant Yale students showcased their amazing research covering:
Disease Surveillance 🕵️♀️
Global Health 🌍
Vaccine Innovations 💉
Epidemic Modeling 📊
Climate and Health 🌱
Health Policy and Ethics 📜
@yalesph.bsky.social
What a day! Our brilliant Yale students showcased their amazing research covering:
Disease Surveillance 🕵️♀️
Global Health 🌍
Vaccine Innovations 💉
Epidemic Modeling 📊
Climate and Health 🌱
Health Policy and Ethics 📜
@yalesph.bsky.social
We're highlighting the lab-based research driving innovation in infectious disease epi at the Yale School of Public Health —from vector-borne and zoonotic threats to emerging pathogens and NTDs.
We're highlighting the lab-based research driving innovation in infectious disease epi at the Yale School of Public Health —from vector-borne and zoonotic threats to emerging pathogens and NTDs.